ProCE Banner Activity

Expert Answers to FAQs on Approaches for Improving Time to Early Effective Therapy for Resistant Gram-Negative Infections

Clinical Thought

Expert faculty discuss answers to commonly asked questions about how to improve time to early effective therapy for patients with resistant gram-negative infections.

Released: March 20, 2023

Expiration: March 18, 2024

Share

Faculty

Elias Chahine

Elias Chahine, PharmD, FCCP, FASCP, FFSHP, BCPS, BCIDP

Professor of Pharmacy Practice
Palm Beach Atlantic University Gregory School of Pharmacy
West Palm Beach, Florida
Clinical Pharmacy Specialist
Pharmacy Services
Wellington Regional Medical Center
Wellington, Florida

Jaclyn Cusumano

Jaclyn Cusumano, PharmD, BCIDP

Assistant Professor
Pharmacy Practice
Long Island University
Brooklyn, New York
Antimicrobial Stewardship Pharmacist
Department of Pharmacy
Mount Sinai Queens Hospital
Astoria, New York

Provided by

ProCE Banner

Supporters

bioMérieux

Partners

Society of Infectious Diseases Pharmacists (SIDP)

ProCE Banner

Faculty Disclosure

Primary Author

Elias Chahine, PharmD, FCCP, FASCP, FFSHP, BCPS, BCIDP

Professor of Pharmacy Practice
Palm Beach Atlantic University Gregory School of Pharmacy
West Palm Beach, Florida
Clinical Pharmacy Specialist
Pharmacy Services
Wellington Regional Medical Center
Wellington, Florida

Elias B. Chahine, PharmD, FCCP, FASCP, FFSHP, BCPS, BCIDP: consultant/advisor/speaker: Gilead, Seqirus, Shinogi, Theratechnologies.

Jaclyn Cusumano, PharmD, BCIDP

Assistant Professor
Pharmacy Practice
Long Island University
Brooklyn, New York
Antimicrobial Stewardship Pharmacist
Department of Pharmacy
Mount Sinai Queens Hospital
Astoria, New York

Jaclyn Cusumano, PharmD, BCIDP: consultant/advisor/speaker: Shionogi.